instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'URSODIOL'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, DOSE INCREASED | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
What was the dosage of drug 'VINCRISTINE'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, R-CHOP REGIMEN | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
What was the outcome of reaction 'Coagulopathy'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | Recovered | ReactionOutcome | CC BY | 34721423 | 20,245,736 | 2021 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | Recovered | ReactionOutcome | CC BY | 34721423 | 20,245,736 | 2021 |
What was the outcome of reaction 'Septic coagulopathy'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | Recovered | ReactionOutcome | CC BY | 34721423 | 20,173,792 | 2021 |
What was the outcome of reaction 'Septic shock'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | Recovered | ReactionOutcome | CC BY | 34721423 | 20,173,792 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | APIXABAN, AZATHIOPRINE, CYCLOPHOSPHAMIDE, ERYTHROPOIETIN, MYCOPHENOLATE MOFETIL, RITUXIMAB, SIROLIMUS, TACROLIMUS, VINCRISTINE | DrugsGivenReaction | CC BY | 34721429 | 20,181,464 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone marrow failure'. | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | APIXABAN, AZATHIOPRINE, CYCLOPHOSPHAMIDE, ERYTHROPOIETIN, MYCOPHENOLATE MOFETIL, RITUXIMAB, SIROLIMUS, TACROLIMUS, VINCRISTINE | DrugsGivenReaction | CC BY | 34721429 | 20,181,464 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypogammaglobulinaemia'. | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | APIXABAN, AZATHIOPRINE, CYCLOPHOSPHAMIDE, ERYTHROPOIETIN, MYCOPHENOLATE MOFETIL, RITUXIMAB, SIROLIMUS, TACROLIMUS, VINCRISTINE | DrugsGivenReaction | CC BY | 34721429 | 20,186,742 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | APIXABAN, AZATHIOPRINE, CYCLOPHOSPHAMIDE, ERYTHROPOIETIN, MYCOPHENOLATE MOFETIL, RITUXIMAB, SIROLIMUS, TACROLIMUS, VINCRISTINE | DrugsGivenReaction | CC BY | 34721429 | 20,181,464 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | APIXABAN, AZATHIOPRINE, CYCLOPHOSPHAMIDE, ERYTHROPOIETIN, MYCOPHENOLATE MOFETIL, RITUXIMAB, SIROLIMUS, TACROLIMUS, VINCRISTINE | DrugsGivenReaction | CC BY | 34721429 | 20,181,464 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary embolism'. | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | APIXABAN, AZATHIOPRINE, CYCLOPHOSPHAMIDE, ERYTHROPOIETIN, MYCOPHENOLATE MOFETIL, RITUXIMAB, SIROLIMUS, TACROLIMUS, VINCRISTINE | DrugsGivenReaction | CC BY | 34721429 | 20,186,742 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary hypertension'. | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | APIXABAN, AZATHIOPRINE, CYCLOPHOSPHAMIDE, ERYTHROPOIETIN, MYCOPHENOLATE MOFETIL, RITUXIMAB, SIROLIMUS, TACROLIMUS, VINCRISTINE | DrugsGivenReaction | CC BY | 34721429 | 20,181,464 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | APIXABAN, AZATHIOPRINE, CYCLOPHOSPHAMIDE, ERYTHROPOIETIN, MYCOPHENOLATE MOFETIL, RITUXIMAB, SIROLIMUS, TACROLIMUS, VINCRISTINE | DrugsGivenReaction | CC BY | 34721429 | 20,181,464 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | APIXABAN, AZATHIOPRINE, CYCLOPHOSPHAMIDE, ERYTHROPOIETIN, MYCOPHENOLATE MOFETIL, RITUXIMAB, SIROLIMUS, TACROLIMUS, VINCRISTINE | DrugsGivenReaction | CC BY | 34721429 | 20,181,464 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | APIXABAN, AZATHIOPRINE, CYCLOPHOSPHAMIDE, ERYTHROPOIETIN, MYCOPHENOLATE MOFETIL, RITUXIMAB, SIROLIMUS, TACROLIMUS, VINCRISTINE | DrugsGivenReaction | CC BY | 34721429 | 20,186,742 | 2021 |
What was the dosage of drug 'RITUXIMAB'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | CONCENTRATE FOR SOLUTION FOR INFUSION | DrugDosageText | CC BY | 34721429 | 20,181,464 | 2021 |
What was the outcome of reaction 'Anaemia'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | Fatal | ReactionOutcome | CC BY | 34721429 | 20,181,464 | 2021 |
What was the outcome of reaction 'Bone marrow failure'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | Fatal | ReactionOutcome | CC BY | 34721429 | 20,181,464 | 2021 |
What was the outcome of reaction 'Inflammation'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | Fatal | ReactionOutcome | CC BY | 34721429 | 20,181,464 | 2021 |
What was the outcome of reaction 'Intracardiac thrombus'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | Fatal | ReactionOutcome | CC BY | 34721429 | 20,181,464 | 2021 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | Fatal | ReactionOutcome | CC BY | 34721429 | 20,181,464 | 2021 |
What was the outcome of reaction 'Neutropenia'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | Fatal | ReactionOutcome | CC BY | 34721429 | 20,181,464 | 2021 |
What was the outcome of reaction 'Off label use'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | Fatal | ReactionOutcome | CC BY | 34721429 | 20,181,464 | 2021 |
What was the outcome of reaction 'Pulmonary hypertension'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | Fatal | ReactionOutcome | CC BY | 34721429 | 20,181,464 | 2021 |
What was the outcome of reaction 'Pyrexia'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | Fatal | ReactionOutcome | CC BY | 34721429 | 20,181,464 | 2021 |
What was the outcome of reaction 'Sepsis'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | Fatal | ReactionOutcome | CC BY | 34721429 | 20,181,464 | 2021 |
What was the outcome of reaction 'Septic shock'? | Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, such as vasculitis, inflammatio... | Fatal | ReactionOutcome | CC BY | 34721429 | 20,181,464 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arrhythmia'. | A case of paroxysmal complete atrioventricular block in a COVID-19 patient.
Many types of cardiac arrhythmias can occur in people with COVID-19, and these arrhythmias can affect the patient's outcomes. We have experienced paroxysmal complete atrioventricular block in a patient with COVID-19 and would like to share the ... | AZITHROMYCIN, FENTANYL CITRATE, MIDAZOLAM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY | 34721847 | 20,239,045 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrioventricular block complete'. | A case of paroxysmal complete atrioventricular block in a COVID-19 patient.
Many types of cardiac arrhythmias can occur in people with COVID-19, and these arrhythmias can affect the patient's outcomes. We have experienced paroxysmal complete atrioventricular block in a patient with COVID-19 and would like to share the ... | AZITHROMYCIN, FENTANYL CITRATE, MIDAZOLAM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY | 34721847 | 20,239,045 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paroxysmal atrioventricular block'. | A case of paroxysmal complete atrioventricular block in a COVID-19 patient.
Many types of cardiac arrhythmias can occur in people with COVID-19, and these arrhythmias can affect the patient's outcomes. We have experienced paroxysmal complete atrioventricular block in a patient with COVID-19 and would like to share the ... | AZITHROMYCIN, COBICISTAT\DARUNAVIR ETHANOLATE, FENTANYL CITRATE, LEVOFLOXACIN, LOPINAVIR\RITONAVIR, MIDAZOLAM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY | 34721847 | 20,316,635 | 2021-10 |
What was the outcome of reaction 'Arrhythmia'? | A case of paroxysmal complete atrioventricular block in a COVID-19 patient.
Many types of cardiac arrhythmias can occur in people with COVID-19, and these arrhythmias can affect the patient's outcomes. We have experienced paroxysmal complete atrioventricular block in a patient with COVID-19 and would like to share the ... | Recovered | ReactionOutcome | CC BY | 34721847 | 20,239,045 | 2021-10 |
What was the outcome of reaction 'Atrioventricular block complete'? | A case of paroxysmal complete atrioventricular block in a COVID-19 patient.
Many types of cardiac arrhythmias can occur in people with COVID-19, and these arrhythmias can affect the patient's outcomes. We have experienced paroxysmal complete atrioventricular block in a patient with COVID-19 and would like to share the ... | Recovered | ReactionOutcome | CC BY | 34721847 | 20,239,045 | 2021-10 |
What was the outcome of reaction 'Paroxysmal atrioventricular block'? | A case of paroxysmal complete atrioventricular block in a COVID-19 patient.
Many types of cardiac arrhythmias can occur in people with COVID-19, and these arrhythmias can affect the patient's outcomes. We have experienced paroxysmal complete atrioventricular block in a patient with COVID-19 and would like to share the ... | Recovered | ReactionOutcome | CC BY | 34721847 | 20,316,635 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Atypical presentation of cardiomyopathy in a case of maternal mortality that was demonstrated as hypovolemic shock.
Periconceptional and prenatal care should be continued even during COVID-19 pandemics. Indeed, prevention and intervention programs for managing heart failure with aggressive resuscitation and invasive mo... | ACETAMINOPHEN, ATROPINE, EPINEPHRINE, FENTANYL, FUROSEMIDE, LIDOCAINE, MIDAZOLAM, OXYTOCIN, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34721867 | 20,616,534 | 2021-10 |
What was the administration route of drug 'ACETAMINOPHEN'? | Atypical presentation of cardiomyopathy in a case of maternal mortality that was demonstrated as hypovolemic shock.
Periconceptional and prenatal care should be continued even during COVID-19 pandemics. Indeed, prevention and intervention programs for managing heart failure with aggressive resuscitation and invasive mo... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34721867 | 20,616,534 | 2021-10 |
What was the administration route of drug 'LIDOCAINE'? | Atypical presentation of cardiomyopathy in a case of maternal mortality that was demonstrated as hypovolemic shock.
Periconceptional and prenatal care should be continued even during COVID-19 pandemics. Indeed, prevention and intervention programs for managing heart failure with aggressive resuscitation and invasive mo... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34721867 | 20,616,534 | 2021-10 |
What was the administration route of drug 'OXYTOCIN'? | Atypical presentation of cardiomyopathy in a case of maternal mortality that was demonstrated as hypovolemic shock.
Periconceptional and prenatal care should be continued even during COVID-19 pandemics. Indeed, prevention and intervention programs for managing heart failure with aggressive resuscitation and invasive mo... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34721867 | 20,616,534 | 2021-10 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Atypical presentation of cardiomyopathy in a case of maternal mortality that was demonstrated as hypovolemic shock.
Periconceptional and prenatal care should be continued even during COVID-19 pandemics. Indeed, prevention and intervention programs for managing heart failure with aggressive resuscitation and invasive mo... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34721867 | 20,616,534 | 2021-10 |
What was the dosage of drug 'EPINEPHRINE'? | Atypical presentation of cardiomyopathy in a case of maternal mortality that was demonstrated as hypovolemic shock.
Periconceptional and prenatal care should be continued even during COVID-19 pandemics. Indeed, prevention and intervention programs for managing heart failure with aggressive resuscitation and invasive mo... | UNK, DRIP | DrugDosageText | CC BY | 34721867 | 20,616,534 | 2021-10 |
What was the dosage of drug 'FENTANYL'? | Atypical presentation of cardiomyopathy in a case of maternal mortality that was demonstrated as hypovolemic shock.
Periconceptional and prenatal care should be continued even during COVID-19 pandemics. Indeed, prevention and intervention programs for managing heart failure with aggressive resuscitation and invasive mo... | UNK; DRIP | DrugDosageText | CC BY | 34721867 | 20,616,534 | 2021-10 |
What was the dosage of drug 'OXYTOCIN'? | Atypical presentation of cardiomyopathy in a case of maternal mortality that was demonstrated as hypovolemic shock.
Periconceptional and prenatal care should be continued even during COVID-19 pandemics. Indeed, prevention and intervention programs for managing heart failure with aggressive resuscitation and invasive mo... | 30 INTERNATIONAL UNIT | DrugDosageText | CC BY | 34721867 | 20,616,534 | 2021-10 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Atypical presentation of cardiomyopathy in a case of maternal mortality that was demonstrated as hypovolemic shock.
Periconceptional and prenatal care should be continued even during COVID-19 pandemics. Indeed, prevention and intervention programs for managing heart failure with aggressive resuscitation and invasive mo... | 500 MILLILITER | DrugDosageText | CC BY | 34721867 | 20,616,534 | 2021-10 |
What was the outcome of reaction 'Drug ineffective'? | Atypical presentation of cardiomyopathy in a case of maternal mortality that was demonstrated as hypovolemic shock.
Periconceptional and prenatal care should be continued even during COVID-19 pandemics. Indeed, prevention and intervention programs for managing heart failure with aggressive resuscitation and invasive mo... | Fatal | ReactionOutcome | CC BY | 34721867 | 20,616,534 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac arrest'. | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | ASPIRIN, ATORVASTATIN, BISOPROLOL, CLOPIDOGREL BISULFATE, ENOXAPARIN, FUROSEMIDE, INSULIN NOS, ISOSORBIDE MONONITRATE, METOPROLOL TARTRATE, SPIRONOLACTONE, TICAGRELOR | DrugsGivenReaction | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the administration route of drug 'ENOXAPARIN'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | Subcutaneous | DrugAdministrationRoute | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the administration route of drug 'TICAGRELOR'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | Oral | DrugAdministrationRoute | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the dosage of drug 'ATORVASTATIN'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | 20 MG | DrugDosageText | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the dosage of drug 'BISOPROLOL'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | 5 MG | DrugDosageText | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the dosage of drug 'CLOPIDOGREL BISULFATE'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | 300 MG THEN 75 MG DAILY | DrugDosageText | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the dosage of drug 'ENOXAPARIN'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | 1 MG/KG EVERY 12 H | DrugDosageText | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the dosage of drug 'FUROSEMIDE'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | 40 MG INTRAVENOUS TWICE DAILY | DrugDosageText | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the dosage of drug 'ISOSORBIDE MONONITRATE'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | 20 MG | DrugDosageText | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the dosage of drug 'METOPROLOL TARTRATE'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | 50 MG | DrugDosageText | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the dosage of drug 'SPIRONOLACTONE'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | 12.5 MG DAILY | DrugDosageText | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the dosage of drug 'TICAGRELOR'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | 180 MG AS A LOADING DOSE FOLLOWED BY 90 MG TWICE DAILY | DrugDosageText | CC BY | 34721870 | 20,189,406 | 2021-10 |
What was the outcome of reaction 'Cardiac arrest'? | Prolonged ventricular pause associated with ticagrelor use: A case report.
We report a case of a 76-year-old female who presented with non-ST elevation myocardial infarction and developed a 22-second ventricular pause with ticagrelor that did not recur after shifting to clopidogrel. Based on the Naranjo algorithm, the ... | Recovered | ReactionOutcome | CC BY | 34721870 | 20,189,406 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthma'. | Successful management of severe bronchial asthma exacerbated by anti-PD-L1 treatment: A report of two cases.
Immune checkpoint inhibitors (ICIs) have been used for various carcinomas. However, immune-related adverse events have been observed. There have been few reports of treatment with biologics for severe bronchial ... | BUDESONIDE\FORMOTEROL, DURVALUMAB, LINAGLIPTIN, PREDNISOLONE | DrugsGivenReaction | CC BY | 34721879 | 20,152,392 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Successful management of severe bronchial asthma exacerbated by anti-PD-L1 treatment: A report of two cases.
Immune checkpoint inhibitors (ICIs) have been used for various carcinomas. However, immune-related adverse events have been observed. There have been few reports of treatment with biologics for severe bronchial ... | BUDESONIDE\FORMOTEROL, DURVALUMAB, LINAGLIPTIN, PREDNISOLONE | DrugsGivenReaction | CC BY | 34721879 | 20,152,392 | 2021-11 |
What was the administration route of drug 'BUDESONIDE\FORMOTEROL'? | Successful management of severe bronchial asthma exacerbated by anti-PD-L1 treatment: A report of two cases.
Immune checkpoint inhibitors (ICIs) have been used for various carcinomas. However, immune-related adverse events have been observed. There have been few reports of treatment with biologics for severe bronchial ... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY | 34721879 | 20,152,392 | 2021-11 |
What was the administration route of drug 'LINAGLIPTIN'? | Successful management of severe bronchial asthma exacerbated by anti-PD-L1 treatment: A report of two cases.
Immune checkpoint inhibitors (ICIs) have been used for various carcinomas. However, immune-related adverse events have been observed. There have been few reports of treatment with biologics for severe bronchial ... | Oral | DrugAdministrationRoute | CC BY | 34721879 | 20,152,392 | 2021-11 |
What was the administration route of drug 'PREDNISOLONE'? | Successful management of severe bronchial asthma exacerbated by anti-PD-L1 treatment: A report of two cases.
Immune checkpoint inhibitors (ICIs) have been used for various carcinomas. However, immune-related adverse events have been observed. There have been few reports of treatment with biologics for severe bronchial ... | Oral | DrugAdministrationRoute | CC BY | 34721879 | 20,152,392 | 2021-11 |
What was the dosage of drug 'BUDESONIDE\FORMOTEROL'? | Successful management of severe bronchial asthma exacerbated by anti-PD-L1 treatment: A report of two cases.
Immune checkpoint inhibitors (ICIs) have been used for various carcinomas. However, immune-related adverse events have been observed. There have been few reports of treatment with biologics for severe bronchial ... | (BUDESONIDE/FORMOTEROL): BUDESONIDE: 320 UG; FORMOTEROL: 9 UG; | DrugDosageText | CC BY | 34721879 | 20,152,392 | 2021-11 |
What was the dosage of drug 'LINAGLIPTIN'? | Successful management of severe bronchial asthma exacerbated by anti-PD-L1 treatment: A report of two cases.
Immune checkpoint inhibitors (ICIs) have been used for various carcinomas. However, immune-related adverse events have been observed. There have been few reports of treatment with biologics for severe bronchial ... | 5 mg (milligrams). | DrugDosage | CC BY | 34721879 | 20,152,392 | 2021-11 |
What was the outcome of reaction 'Asthma'? | Successful management of severe bronchial asthma exacerbated by anti-PD-L1 treatment: A report of two cases.
Immune checkpoint inhibitors (ICIs) have been used for various carcinomas. However, immune-related adverse events have been observed. There have been few reports of treatment with biologics for severe bronchial ... | Recovered | ReactionOutcome | CC BY | 34721879 | 20,152,392 | 2021-11 |
What was the outcome of reaction 'Hyperglycaemia'? | Successful management of severe bronchial asthma exacerbated by anti-PD-L1 treatment: A report of two cases.
Immune checkpoint inhibitors (ICIs) have been used for various carcinomas. However, immune-related adverse events have been observed. There have been few reports of treatment with biologics for severe bronchial ... | Recovered | ReactionOutcome | CC BY | 34721879 | 20,152,392 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis B reactivation'. | Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia.
Ibrutinib is a targeted therapy drug that blocks the activity of Bruton's tyrosine kinase, and it is an approved treatment for several mature B-cell malignancies including chronic lymphocytic leukaemia ... | CYCLOPHOSPHAMIDE, DICLOFENAC SODIUM, FLUDARABINE PHOSPHATE, IBRUTINIB, PIPERACILLIN, RITUXIMAB, TAZOBACTAM, TENOFOVIR, VENETOCLAX | DrugsGivenReaction | CC BY | 34721911 | 20,200,690 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia.
Ibrutinib is a targeted therapy drug that blocks the activity of Bruton's tyrosine kinase, and it is an approved treatment for several mature B-cell malignancies including chronic lymphocytic leukaemia ... | CYCLOPHOSPHAMIDE, DICLOFENAC SODIUM, FLUDARABINE PHOSPHATE, IBRUTINIB, PIPERACILLIN, RITUXIMAB, TAZOBACTAM, TENOFOVIR, VENETOCLAX | DrugsGivenReaction | CC BY | 34721911 | 20,200,690 | 2021 |
What was the outcome of reaction 'Sepsis'? | Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia.
Ibrutinib is a targeted therapy drug that blocks the activity of Bruton's tyrosine kinase, and it is an approved treatment for several mature B-cell malignancies including chronic lymphocytic leukaemia ... | Fatal | ReactionOutcome | CC BY | 34721911 | 20,200,690 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ascites'. | A Case of Hepatitis C-Related Decompensated Cirrhosis Observed by MRI Imaging Data During Treatment With Direct-Acting Antiviral Agents.
Sofosbuvir/velpatasvir therapy can safely treat hepatitis C virus (HCV)-related decompensated cirrhosis and has been shown to improve liver function at an early stage. However, the pa... | FUROSEMIDE, LACTULOSE, SOFOSBUVIR\VELPATASVIR, SPIRONOLACTONE | DrugsGivenReaction | CC BY | 34722009 | 20,039,393 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Spleen disorder'. | A Case of Hepatitis C-Related Decompensated Cirrhosis Observed by MRI Imaging Data During Treatment With Direct-Acting Antiviral Agents.
Sofosbuvir/velpatasvir therapy can safely treat hepatitis C virus (HCV)-related decompensated cirrhosis and has been shown to improve liver function at an early stage. However, the pa... | FUROSEMIDE, LACTULOSE, SOFOSBUVIR\VELPATASVIR, SPIRONOLACTONE | DrugsGivenReaction | CC BY | 34722009 | 20,039,393 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Varices oesophageal'. | A Case of Hepatitis C-Related Decompensated Cirrhosis Observed by MRI Imaging Data During Treatment With Direct-Acting Antiviral Agents.
Sofosbuvir/velpatasvir therapy can safely treat hepatitis C virus (HCV)-related decompensated cirrhosis and has been shown to improve liver function at an early stage. However, the pa... | FUROSEMIDE, LACTULOSE, SOFOSBUVIR\VELPATASVIR, SPIRONOLACTONE | DrugsGivenReaction | CC BY | 34722009 | 20,039,393 | 2021-10 |
What is the weight of the patient? | A Case of Hepatitis C-Related Decompensated Cirrhosis Observed by MRI Imaging Data During Treatment With Direct-Acting Antiviral Agents.
Sofosbuvir/velpatasvir therapy can safely treat hepatitis C virus (HCV)-related decompensated cirrhosis and has been shown to improve liver function at an early stage. However, the pa... | 86.2 kg. | Weight | CC BY | 34722009 | 20,039,393 | 2021-10 |
What was the outcome of reaction 'Ascites'? | A Case of Hepatitis C-Related Decompensated Cirrhosis Observed by MRI Imaging Data During Treatment With Direct-Acting Antiviral Agents.
Sofosbuvir/velpatasvir therapy can safely treat hepatitis C virus (HCV)-related decompensated cirrhosis and has been shown to improve liver function at an early stage. However, the pa... | Recovering | ReactionOutcome | CC BY | 34722009 | 20,039,393 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance.
Mechanisms of COVID-19 coagulopathy have been speculated and are not definitively understood; the current speculation is that there is elaborate crosstalk between the inflammatory and hemostatic systems which contributes to the overall increa... | HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34722046 | 20,695,849 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance.
Mechanisms of COVID-19 coagulopathy have been speculated and are not definitively understood; the current speculation is that there is elaborate crosstalk between the inflammatory and hemostatic systems which contributes to the overall increa... | ARGATROBAN, FONDAPARINUX, HEPARIN SODIUM, WARFARIN | DrugsGivenReaction | CC BY | 34722046 | 20,784,757 | 2021-09 |
What was the administration route of drug 'HEPARIN SODIUM'? | A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance.
Mechanisms of COVID-19 coagulopathy have been speculated and are not definitively understood; the current speculation is that there is elaborate crosstalk between the inflammatory and hemostatic systems which contributes to the overall increa... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34722046 | 20,695,849 | 2021-09 |
What was the dosage of drug 'ARGATROBAN'? | A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance.
Mechanisms of COVID-19 coagulopathy have been speculated and are not definitively understood; the current speculation is that there is elaborate crosstalk between the inflammatory and hemostatic systems which contributes to the overall increa... | UNKNOWN | DrugDosageText | CC BY | 34722046 | 20,784,757 | 2021-09 |
What was the dosage of drug 'FONDAPARINUX'? | A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance.
Mechanisms of COVID-19 coagulopathy have been speculated and are not definitively understood; the current speculation is that there is elaborate crosstalk between the inflammatory and hemostatic systems which contributes to the overall increa... | UNKNOWN | DrugDosageText | CC BY | 34722046 | 20,784,757 | 2021-09 |
What was the dosage of drug 'HEPARIN SODIUM'? | A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance.
Mechanisms of COVID-19 coagulopathy have been speculated and are not definitively understood; the current speculation is that there is elaborate crosstalk between the inflammatory and hemostatic systems which contributes to the overall increa... | UNKNOWN | DrugDosageText | CC BY | 34722046 | 20,784,757 | 2021-09 |
What was the dosage of drug 'WARFARIN'? | A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance.
Mechanisms of COVID-19 coagulopathy have been speculated and are not definitively understood; the current speculation is that there is elaborate crosstalk between the inflammatory and hemostatic systems which contributes to the overall increa... | UNKNOWN | DrugDosageText | CC BY | 34722046 | 20,784,757 | 2021-09 |
What was the outcome of reaction 'Drug ineffective'? | A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance.
Mechanisms of COVID-19 coagulopathy have been speculated and are not definitively understood; the current speculation is that there is elaborate crosstalk between the inflammatory and hemostatic systems which contributes to the overall increa... | Fatal | ReactionOutcome | CC BY | 34722046 | 20,695,849 | 2021-09 |
What was the outcome of reaction 'Heparin resistance'? | A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance.
Mechanisms of COVID-19 coagulopathy have been speculated and are not definitively understood; the current speculation is that there is elaborate crosstalk between the inflammatory and hemostatic systems which contributes to the overall increa... | Fatal | ReactionOutcome | CC BY | 34722046 | 20,695,849 | 2021-09 |
What was the outcome of reaction 'Hypercoagulation'? | A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance.
Mechanisms of COVID-19 coagulopathy have been speculated and are not definitively understood; the current speculation is that there is elaborate crosstalk between the inflammatory and hemostatic systems which contributes to the overall increa... | Fatal | ReactionOutcome | CC BY | 34722046 | 20,784,757 | 2021-09 |
What was the outcome of reaction 'Treatment failure'? | A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance.
Mechanisms of COVID-19 coagulopathy have been speculated and are not definitively understood; the current speculation is that there is elaborate crosstalk between the inflammatory and hemostatic systems which contributes to the overall increa... | Fatal | ReactionOutcome | CC BY | 34722046 | 20,784,757 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Macroscopic to Microscopic - A Case of Crohn's Disease Progressing to Collagenous Colitis.
The association between microscopic colitis (MC) and inflammatory bowel disease (IBD) is uncertain and infrequently reported. Rare cases in the literature consist of simultaneous MC and IBD, or progression of one condition to the... | ADALIMUMAB | DrugsGivenReaction | CC BY | 34722074 | 17,434,085 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Fourteen-Year-Old Boy With Intracranial Internal Carotid Artery Aneurysm Presenting as Mood Disorder.
Intracranial aneurysms (IA) are very uncommon to find in the pediatric population. If present, it is usually associated with other genetic illnesses. Most of the intracranial aneurysm has been presented due to mass eff... | FLUNARIZINE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34722088 | 20,079,974 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Subarachnoid haemorrhage'. | Fourteen-Year-Old Boy With Intracranial Internal Carotid Artery Aneurysm Presenting as Mood Disorder.
Intracranial aneurysms (IA) are very uncommon to find in the pediatric population. If present, it is usually associated with other genetic illnesses. Most of the intracranial aneurysm has been presented due to mass eff... | FLUNARIZINE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34722088 | 20,079,974 | 2021-09 |
What was the outcome of reaction 'Condition aggravated'? | Fourteen-Year-Old Boy With Intracranial Internal Carotid Artery Aneurysm Presenting as Mood Disorder.
Intracranial aneurysms (IA) are very uncommon to find in the pediatric population. If present, it is usually associated with other genetic illnesses. Most of the intracranial aneurysm has been presented due to mass eff... | Recovered | ReactionOutcome | CC BY | 34722088 | 20,079,974 | 2021-09 |
What was the outcome of reaction 'Subarachnoid haemorrhage'? | Fourteen-Year-Old Boy With Intracranial Internal Carotid Artery Aneurysm Presenting as Mood Disorder.
Intracranial aneurysms (IA) are very uncommon to find in the pediatric population. If present, it is usually associated with other genetic illnesses. Most of the intracranial aneurysm has been presented due to mass eff... | Recovered | ReactionOutcome | CC BY | 34722088 | 20,079,974 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases.
Treatment options for patients with advanced sarcoma remain limited. Promising responses to checkpoint inhibition have been observed, but responses to single-agent PD-1 inhibition ... | MELPHALAN, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34722269 | 20,166,617 | 2021 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases.
Treatment options for patients with advanced sarcoma remain limited. Promising responses to checkpoint inhibition have been observed, but responses to single-agent PD-1 inhibition ... | 1 DOSAGE FORM, ONCE | DrugDosageText | CC BY | 34722269 | 20,166,617 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Case Report: Identification of a Novel GNAS Mutation and 1p/22q Co-Deletion in a Patient With Multiple Recurrent Meningiomas Sensitive to Sunitinib.
Although surgical resection can cure the majority of meningiomas, there are still approximately 20% of patients suffering from an aggressive course with recurrence or prog... | SUNITINIB, TEMOZOLOMIDE | DrugsGivenReaction | CC BY | 34722286 | 20,472,194 | 2021 |
What was the dosage of drug 'SUNITINIB'? | Case Report: Identification of a Novel GNAS Mutation and 1p/22q Co-Deletion in a Patient With Multiple Recurrent Meningiomas Sensitive to Sunitinib.
Although surgical resection can cure the majority of meningiomas, there are still approximately 20% of patients suffering from an aggressive course with recurrence or prog... | 50 MILLIGRAM, DAILY | DrugDosageText | CC BY | 34722286 | 20,472,194 | 2021 |
What was the dosage of drug 'TEMOZOLOMIDE'? | Case Report: Identification of a Novel GNAS Mutation and 1p/22q Co-Deletion in a Patient With Multiple Recurrent Meningiomas Sensitive to Sunitinib.
Although surgical resection can cure the majority of meningiomas, there are still approximately 20% of patients suffering from an aggressive course with recurrence or prog... | 75 MILLIGRAM/SQ. METER | DrugDosageText | CC BY | 34722286 | 20,472,194 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchopulmonary aspergillosis'. | Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents.
Background: The prognosis of refractory/relapsed B-cell precursor acute lymphoblastic leukemia (BCP-ALL) remains dismal owing to acquired resist... | CYCLOPHOSPHAMIDE, ETOPOSIDE, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, METHOTREXATE SODIUM, PREDNISOLONE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TACROLIMUS | DrugsGivenReaction | CC BY | 34722423 | 20,546,386 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphoproliferative disorder'. | Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents.
Background: The prognosis of refractory/relapsed B-cell precursor acute lymphoblastic leukemia (BCP-ALL) remains dismal owing to acquired resist... | CYCLOPHOSPHAMIDE, ETOPOSIDE, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, METHOTREXATE SODIUM, PREDNISOLONE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TACROLIMUS | DrugsGivenReaction | CC BY | 34722423 | 20,546,382 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary haemorrhage'. | Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents.
Background: The prognosis of refractory/relapsed B-cell precursor acute lymphoblastic leukemia (BCP-ALL) remains dismal owing to acquired resist... | CYCLOPHOSPHAMIDE, ETOPOSIDE, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, METHOTREXATE SODIUM, PREDNISOLONE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TACROLIMUS | DrugsGivenReaction | CC BY | 34722423 | 20,546,386 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents.
Background: The prognosis of refractory/relapsed B-cell precursor acute lymphoblastic leukemia (BCP-ALL) remains dismal owing to acquired resist... | CYCLOPHOSPHAMIDE, ETOPOSIDE, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, METHOTREXATE SODIUM, PREDNISOLONE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TACROLIMUS | DrugsGivenReaction | CC BY | 34722423 | 20,546,326 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stenotrophomonas infection'. | Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents.
Background: The prognosis of refractory/relapsed B-cell precursor acute lymphoblastic leukemia (BCP-ALL) remains dismal owing to acquired resist... | CYCLOPHOSPHAMIDE, ETOPOSIDE, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, METHOTREXATE SODIUM, PREDNISOLONE, SULFAMETHOXAZOLE\TRIMETHOPRIM, TACROLIMUS | DrugsGivenReaction | CC BY | 34722423 | 20,546,326 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.